Design of New Uracil Derivatives Possessing Inhibitory Activity with Respect to Reverse Transcriptase of HIV-1 Mutant K103N/Y181C


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

New highly active N1-substituted uracil derivatives of the HIV-1 nonnucleoside reverse transcriptase inhibitor class were designed. The structure—activity relationship provided a basis for building a computer model of the inhibitory activity against reverse transcriptase of HIV-1 mutant K103N/Y181C. New compounds that were more active than nevirapine were synthesized.

作者简介

S. Pechinskii

Pyatigorsk Medico-Pharmaceutical Institute, Branch of Volgograd State Medical University

Email: chem@folium.ru
俄罗斯联邦, MH RF, Pyatigorsk, 357532

A. Kuregyan

Pyatigorsk Medico-Pharmaceutical Institute, Branch of Volgograd State Medical University

Email: chem@folium.ru
俄罗斯联邦, MH RF, Pyatigorsk, 357532

A. Ozerov

Volgograd State Medical University, MH RF

Email: chem@folium.ru
俄罗斯联邦, Volgograd, 400131

M. Novikov

Volgograd State Medical University, MH RF

Email: chem@folium.ru
俄罗斯联邦, Volgograd, 400131

补充文件

附件文件
动作
1. JATS XML

版权所有 © Springer Science+Business Media New York, 2016